OrganiGram Holdings Inc.
Health
Performance
7.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

OrganiGram Holdings Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

01.01.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
01.01.2026
Danger zone. Balance sheet’s flashing red across the board.
25.12.2025
Momentum tanked. Clearly underperforming.
23.12.2025
Trouble brewing. Volatility and pressure rising.

OrganiGram Holdings Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does OrganiGram Holdings Inc. do? Business model and key facts

Get the full picture of OrganiGram Holdings Inc.: what it builds, where it operates, and how it makes money.

OrganiGram Holdings Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 1093

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

shop
Company facts
James H. Yamanaka
CEO
1093
Employees worldwide
shop
Performance
0%
Last 12 months
-76.09%
Last 5 years
shop
Growth
$259,18M
Revenue year
$-24.759.000
Net income
shop
Valuation
$299,85M
Market Cap
-14.54
Price/Earnings Ratio

Stocks related to OrganiGram Holdings Inc.

Selected based on industry alignment and relative market positioning.

EOLS
Evolus, Inc.
4.95
+2.70%
8.5
Sell
Buy
Evolus, Inc.
LFCR
Lifecore Biomedical, Inc.
8.67
-1.70%
5.3
Sell
Buy
Lifecore Biomedical, Inc.
SNDL
SNDL Inc.
1.60
+0.63%
8.7
Sell
Buy
SNDL Inc.
OGI
Organigram Global Inc.
1.65
+3.13%
7.6
Sell
Buy
Organigram Global Inc.
ZYBT
Zhengye Biotechnology Holding Limited
1.02
-0.97%
8.0
Sell
Buy
Zhengye Biotechnology Holding Limited

OrganiGram Holdings Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.